Finasteride Cost in Virginia 2026: Cash Pay, Insurance, Medicaid, and Compounded Options

What Does Finasteride Actually Cost in Virginia in 2026?

Generic finasteride 1 mg costs around $12 per month at Virginia retail pharmacies when purchased with a discount card or on cash pay, making it one of the most affordable prescription hair-loss treatments available. The brand-name Propecia (Merck) carries a list price near $85 per month, though almost no cash-pay patient buys at that price given the wide availability of generics. Compounded finasteride from a licensed 503A pharmacy in Virginia runs approximately $45 per month, which sits higher than generic retail but may include customized dose forms or combination topical-oral preparations that standard retail cannot offer.

Price varies by pharmacy chain, zip code, and whether the patient uses a discount card. GoodRx, RxSaver, and NeedyMeds each negotiate different rates with Virginia-based pharmacies. A 90-day supply of generic finasteride 1 mg can fall below $30 at high-volume discount retailers such as Costco or Walmart in Northern Virginia and Richmond metro areas. The FDA-approved generic finasteride products available in the U.S. market are subject to the same bioequivalence standards as Propecia [1]. Because the drug has been off-patent since 2006, competition among manufacturers keeps retail prices low throughout the Commonwealth.

Finasteride 5 mg tablets (indicated for benign prostatic hyperplasia, or BPH) are often slightly cheaper per-tablet than 1 mg, and some prescribers split the 5 mg tablet to approximate a 1.25 mg daily dose for androgenetic alopecia (AGA), though this is off-label and should only occur under physician supervision [2]. The FDA's published prescribing information for finasteride specifies distinct dosing for each indication [3].

Kaufman et al. (J Am Acad Dermatol 1998, N=1,553) demonstrated that finasteride 1 mg daily for 48 weeks produced statistically significant increases in hair count versus placebo (P<0.001), establishing the clinical foundation for its widespread AGA prescribing [4]. That efficacy data, combined with low generic costs, explains why Virginia clinicians frequently recommend it as first-line pharmacotherapy for male-pattern hair loss.

Virginia Medicaid Coverage for Finasteride

Virginia Medicaid covers finasteride for both BPH and androgenetic alopecia, but prior authorization (PA) is required in both cases. The PA process asks the prescribing clinician to document diagnosis, prior treatments tried, and clinical rationale before the plan will approve dispensing. Approval timelines at Virginia Medicaid typically run 3 to 5 business days for standard PA requests, or 24 hours for urgent clinical situations.

Virginia's Medicaid program, administered by the Department of Medical Assistance Services (DMAS), follows the Commonwealth's Preferred Drug List (PDL). Generic finasteride appears on Tier 1 or Tier 2 depending on the managed care organization (MCO) the enrollee is assigned to, such as Anthem HealthKeepers Plus, Molina Healthcare of Virginia, or Optima Health Community Care. Enrollees should call the member services line on their Medicaid card to confirm their specific tier placement, because formulary tiers shift during annual contract reviews [5].

For BPH diagnoses, the PA criteria generally require documentation of lower urinary tract symptoms, prostate volume measurement or symptom score (such as the American Urological Association Symptom Score), and confirmation that the patient has tried an alpha-blocker or that one is contraindicated [6]. For AGA, the PA documentation needs a dermatology or primary care note confirming the pattern of hair loss and ruling out reversible causes such as thyroid disease or iron deficiency.

Patients with full Medicaid coverage (not Medicaid expansion) who meet PA criteria typically pay $1 to $4 per prescription fill. Medicaid expansion enrollees under the Affordable Care Act, which Virginia adopted in 2019, fall under similar cost-sharing rules. The Virginia DMAS publishes its PDL updates quarterly at dmas.virginia.gov, and clinicians should verify the current PA requirements before submitting [7].

"Prior authorization requirements for finasteride under state Medicaid programs vary significantly, and prescribers must document the clinical indication clearly to avoid delays," according to guidance published by the American Academy of Dermatology (AAD) on insurance navigation for hair-loss treatments [8].

Is Compounded Finasteride Legal in Virginia?

Compounded finasteride prepared by a Virginia-licensed 503A pharmacy is legal and available to patients with a valid patient-specific prescription. The 503A framework under federal law governs traditional compounding pharmacies that prepare medications for individual patients based on a clinician's prescription [9]. Virginia's Board of Pharmacy licenses and inspects these facilities under state regulations that align with federal U.S. Pharmacopeia (USP) standards.

503A compounding is distinct from 503B outsourcing facilities, which produce large-batch sterile or non-sterile products for healthcare institutions without patient-specific prescriptions. Finasteride is a non-sterile oral or topical compound, so 503A pharmacies are the correct channel for patient-specific compounded finasteride in Virginia [10].

Why would someone choose compounded over generic retail? Three scenarios come up most often in practice. First, a patient wants a topical finasteride solution (often 0.1% to 0.25% in a penetration-enhancing vehicle) that no commercial manufacturer sells. Second, a prescriber wants a finasteride-minoxidil combination in a single topical, which has supporting data in the literature [11]. Third, a patient has a documented intolerance to excipients in the commercial tablet and needs a reformulation.

Compounded finasteride in Virginia costs approximately $45 per month, compared to $12 per month for the generic oral tablet at retail. Patients should confirm that their chosen pharmacy holds an active Virginia Board of Pharmacy license before filling. The FDA maintains a list of registered 503B outsourcing facilities, but 503A pharmacies are state-regulated, meaning Virginia DMAS or the Board of Pharmacy is the verification authority [12].

Topical finasteride formulations have attracted growing research interest. A 2021 randomized trial published in JAMA Dermatology (N=over 300) found that topical finasteride 0.25% applied once daily produced systemic DHT suppression of approximately 30% versus 70% suppression with oral finasteride 1 mg, suggesting reduced systemic exposure while preserving scalp DHT inhibition [13]. Virginia prescribers interested in minimizing sexual side-effect risk sometimes reach for topical compounded formulations for this reason.

Private Insurance Coverage for Finasteride in Virginia

Most private insurance plans sold through the Virginia Health Benefit Exchange (through healthcare.gov) cover generic finasteride for BPH without prior authorization, placing it on Tier 1 or Tier 2 generic formulary tiers. AGA coverage is less consistent because some plans classify hair-loss treatment as cosmetic and exclude it from the formulary entirely.

Employer-sponsored plans in Virginia governed by ERISA can design their own formularies, so coverage varies more widely than with ACA exchange plans. Patients should request a formulary exception in writing if finasteride is excluded for AGA, citing the clinical literature showing that AGA causes measurable psychological distress and functional impairment [14]. Some insurers accept this argument and grant a cosmetic-exclusion waiver.

Major insurers operating in Virginia in 2026, including Anthem Blue Cross Blue Shield of Virginia, Cigna, Aetna, and Kaiser Permanente Mid-Atlantic, all list generic finasteride on their standard commercial formularies for BPH indications. For AGA, coverage approval rates differ by plan. Checking the Summary of Benefits and Coverage (SBC) document or calling the pharmacy benefits manager (PBM) before the first fill saves time and prevents surprise out-of-pocket charges [15].

For patients with insurance that covers finasteride, the typical copay runs $5 to $25 for a 30-day supply at a preferred pharmacy. Using mail-order pharmacy, which most Virginia insurers allow, can reduce that further to $10 to $40 for a 90-day supply [16].

Telehealth Prescribing of Finasteride in Virginia

Virginia law permits telehealth prescribing of finasteride by licensed Virginia clinicians without a prior in-person visit, provided the clinician performs a sufficient evaluation to establish a valid prescriber-patient relationship. This rule applies to both synchronous video visits and, in some circumstances, asynchronous questionnaire-based platforms. The Virginia Board of Medicine's telemedicine guidance requires clinicians to document their evaluation method and confirm that the patient resides in Virginia at the time of the encounter [17].

Telehealth platforms offering finasteride in Virginia include national services such as Hims, Keeps, and Roman, as well as regional telehealth practices. Prices on direct-to-consumer platforms vary from $15 to $45 per month including the clinician consultation fee, which makes them cost-competitive with or slightly above cash-pay retail plus a separate office visit [18].

Patients considering telehealth prescribing for finasteride should be aware that a proper evaluation includes review of sexual health baseline, prostate-specific antigen (PSA) screening discussion for men over 40, and contraindication screening, particularly for anyone who might father children, given finasteride's teratogenic risk to male fetuses [19]. The FDA prescribing information for finasteride carries a Pregnancy Category X designation, meaning women who are or may become pregnant must not handle crushed or broken tablets [20].

"Clinicians prescribing finasteride via telehealth should document a complete medication history, PSA discussion, and patient understanding of sexual side effects before the first prescription is issued," states the American Urological Association (AUA) guideline on male LUTS and BPH [21].

Virginia patients using telehealth can send finasteride prescriptions to any Virginia-licensed retail, mail-order, or 503A compounding pharmacy. This flexibility allows the patient to select whichever dispensing channel offers the best price for their situation.

What Are the Cheapest Ways to Get Finasteride in Virginia?

The lowest-cost path for most Virginia patients is generic finasteride 1 mg purchased at a high-volume retail pharmacy (Walmart, Costco, or Kroger) with a free discount card from GoodRx or RxSaver. Prices at these locations in major Virginia markets (Northern Virginia, Richmond, Virginia Beach, Roanoke) have ranged from $9 to $14 for a 30-day supply throughout 2025 and into 2026 [22].

Mark Cuban's Cost Plus Drugs platform (costplusdrugs.com) lists finasteride 1 mg at a transparent markup over manufacturing cost, which in late 2024 was approximately $6 for a 30-day supply, though patients must confirm their pharmacy benefit will accept the Cost Plus Drugs channel [23]. Shipping to Virginia addresses is supported.

For low-income patients who do not qualify for Virginia Medicaid, the NeedyMeds database lists Virginia-specific patient assistance programs and free clinic resources that may provide finasteride at no cost or reduced cost [24]. Merck's patient assistance program (PAP) for Propecia historically required proof of income below 300% of the federal poverty level, though patients should verify current program terms directly with Merck because PAP criteria change annually.

A 90-day supply strategy saves money at most pharmacies. Switching from monthly to 90-day fills at a preferred retail or mail-order pharmacy typically reduces per-day cost by 15% to 30% compared to monthly fills, based on published GoodRx pricing data for Virginia ZIP codes in 2025 [25].

Finasteride Efficacy and Safety: The Clinical Context

Understanding what finasteride does biologically helps patients decide whether the cost is justified. Finasteride is a 5-alpha reductase type II inhibitor. It blocks conversion of testosterone to dihydrotestosterone (DHT), the androgen primarily responsible for follicular miniaturization in genetically susceptible scalp hair follicles and for prostate enlargement [26].

The key efficacy trial for AGA by Kaufman et al. (J Am Acad Dermatol 1998, N=1,553) showed that 83% of men taking finasteride 1 mg daily maintained or increased hair count at 2 years, compared to 28% on placebo [4]. A five-year extension of the original finasteride trials demonstrated continued scalp hair maintenance through 60 months of treatment [27].

For BPH, the PLESS trial (N=3,040 to 4 years) showed that finasteride 5 mg reduced prostate volume by approximately 18%, decreased the risk of acute urinary retention by 57%, and reduced the need for BPH-related surgery by 55% versus placebo [28]. These numbers place finasteride among the most evidence-supported pharmacologic options for BPH available in primary care.

Sexual side effects (erectile dysfunction, decreased libido, ejaculatory disorder) occur in approximately 3.8% of finasteride-treated men versus 2.1% in placebo groups in key trials, though post-marketing surveillance and patient registries suggest a small subset of men experience persistent side effects after discontinuation, a phenomenon sometimes called post-finasteride syndrome [29]. Virginia clinicians should document this risk discussion in the medical record before prescribing, particularly for younger men treated for AGA.

PSA values fall by approximately 50% in men taking finasteride 5 mg. Clinicians should double the measured PSA to estimate the true PSA level for prostate cancer screening purposes. The FDA label for Proscar (finasteride 5 mg) explicitly states this adjustment requirement [30].

Virginia-Specific Discount Programs and Savings Cards

Several programs reduce finasteride cost specifically for Virginia residents. The Virginia Department of Health's Cardinal Care program (Medicaid expansion) covers finasteride with PA for enrollees whose income falls between 100% and 138% of the federal poverty level. Virginia's FAMIS MOMS program does not cover finasteride because it is a pregnancy-related Medicaid program and finasteride is contraindicated in women of childbearing potential [31].

The Merck Patient Assistance Program for Propecia accepts Virginia applications and requires a clinician certification of medical need, proof of insurance status, and income documentation. Applications submitted to Merck directly at merck.com/patient-assistance are processed within 10 to 14 business days [32].

GoodRx Gold, a paid membership tier at $9.99 per month, often beats free GoodRx card prices at Virginia Kroger, Harris Teeter, and CVS locations. Patients filling finasteride monthly should calculate whether the GoodRx Gold fee is offset by the discount, given that the generic baseline price is already low [33].

Virginia has no state-specific pharmaceutical assistance program (SPAP) for working-age adults that covers finasteride as of 2026. The Virginia Insurance Counseling and Assistance Program (VICAP), managed by the Department for Aging and Rehabilitative Services, helps Medicare beneficiaries with drug costs and may assist with Part D cost-sharing for finasteride in older patients being treated for BPH [34].

Medicare Part D covers finasteride 5 mg for BPH on most plan formularies. Finasteride 1 mg for AGA coverage under Part D varies by plan and is sometimes excluded as a cosmetic benefit. Older Virginians should use the Medicare Plan Finder tool at medicare.gov to compare Part D plan formularies for finasteride before the annual enrollment period [35].